An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
Nanoparticles (NPs) are promising drug delivery systems (DDS) for identifying and treating cancer. Active targeting NPs can be generated by conjugation with ligands that bind overexpressed or mutant cell surface receptors on target cells that are poorly or not even expressed on normal cells. Recepto...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2020-08-01
|
| Sarja: | Pharmaceutics |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/1999-4923/12/9/802 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|